天奇股份(002009.SZ):全資子公司中標8371萬元湛江三高爐系統原料工程膠帶輸送機(二)、(三)項目
格隆匯5月13日丨天奇股份(002009.SZ)公佈,公司全資子公司銅陵天奇藍天機械設備有限公司(“銅陵藍天”)於近日收到上海寶華國際招標有限公司的中標通知書,確認銅陵藍天中標寶鋼湛江鋼鐵有限公司(“寶鋼湛江”)“湛江三高爐系統原料工程膠帶輸送機(二)、(三)項目”的中標單位,中標金額合計為人民幣8371萬元。
該訂單金額佔公司最近一個經審計會計年度(2019年)營業總收入的2.35%。如項目最終能夠順利實施,預計將對公司2020年經營業績產生積極影響,對公司經營的獨立性不造成影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.